Skip to content
Synaptiq logo — Safe, Personalized, AI-Guided Training for Doctors

Synaptiq

Safe, Personalized, AI-Guided Training for Doctors

Founded 2022 United States San Francisco, United States 7 employees Seed EdTech, Education

General Information

Company Name Synaptiq
Founded Year 2022
Location United States San Francisco, United States
Employees 7
Industries EdTech, Education
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Synaptiq. To contact Synaptiq, visit synaptiq.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Synaptiq compare?

A PDF of Synaptiq and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Synaptiq soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Synaptiq

Synaptiq is an EdTech startup founded in 2022, with the slogan "Safe, Personalized, AI-Guided Training for Doctors". The company's mission is to revolutionize healthcare by providing safe, personalized, AI-guided training to future doctors. Collaborating with medical education companies, publishers, and medical schools, Synaptiq delivers adaptive content tailored to each learner's unique needs. Their platform, grounded in neuroscience, utilizes predictive algorithms and physician-monitored AI to enable thousands of medical trainees to learn twice as thoroughly and 7x faster than any alternative. Their most recent milestone includes securing a Seed Round investment on 29 September 2023 from acclaimed investors such as Y Combinator, Pioneer Fund, and Whatif Ventures. With its headquarters in the United States, Synaptiq is poised to make substantial waves in the healthcare and education sectors, leveraging cutting-edge technology to drive impactful change.

Business keywords: AI-guided training, medical education, personalized learning, healthcare improvement, neuroscience-based platform, predictive algorithms, physician-monitored AI, medical trainees, adaptive learning, medical schools, educational technology, health tech, educational partnerships

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 3
Y Combinator, Pioneer Fund +1
29 Sep 2023

Synaptiq Alternatives & Competitors

View All Alternatives
Synaptiq vs

Çözülmemiş sorunuz kalmasın

18 employees
EdTech, Education
Synaptiq vs

Shaping the future of higher education

Venture round
4 employees
EdTech, Education
Synaptiq vs
Lessonbee
Lessonbee United States

Teach health, check-in, and support individual needs, all in a single platform.

Non Equity Assistance
6 employees
EdTech, Education

FAQ About Synaptiq

Safe, Personalized, AI-Guided Training for Doctors
Synaptiq was founded in 2022.
Synaptiq is headquartered in San Francisco, United States.
Synaptiq operates in EdTech and Education. Its work centres on AI-guided training, medical education, personalized learning and healthcare improvement.
Synaptiq has approximately 7 employees.
Synaptiq has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Synaptiq include Çözücü, Studybees GmbH, Lessonbee, OnlineMedEd, Tarbawi. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synaptiq and Çözücü are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Synaptiq, https://bouncewatch.com/company/synaptiq, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout